Prediction of Cognitive Decline in Parkinson’s Disease Using Clinical and DAT SPECT Imaging Features, and Hybrid Machine Learning Systems
Open Access
- 10 May 2023
- journal article
- research article
- Published by MDPI AG in Diagnostics
- Vol. 13 (10) , 1691
Abstract
Background: We aimed to predict Montreal Cognitive Assessment (MoCA) scores in Parkinson’s disease patients at year 4 using handcrafted radiomics (RF), deep (DF), and clinical (CF) features at year 0 (baseline) applied to hybrid machine learning systems (HMLSs). Methods: 297 patients were selected from the Parkinson’s Progressive Marker Initiative (PPMI) database. The standardized SERA radiomics software and a 3D encoder were employed to extract RFs and DFs from single-photon emission computed tomography (DAT-SPECT) images, respectively. The patients with MoCA scores over 26 were indicated as normal; otherwise, scores under 26 were indicated as abnormal. Moreover, we applied different combinations of feature sets to HMLSs, including the Analysis of Variance (ANOVA) feature selection, which was linked with eight classifiers, including Multi-Layer Perceptron (MLP), K-Neighbors Classifier (KNN), Extra Trees Classifier (ETC), and others. We employed 80% of the patients to select the best model in a 5-fold cross-validation process, and the remaining 20% were employed for hold-out testing. Results: For the sole usage of RFs and DFs, ANOVA and MLP resulted in averaged accuracies of 59 ± 3% and 65 ± 4% for 5-fold cross-validation, respectively, with hold-out testing accuracies of 59 ± 1% and 56 ± 2%, respectively. For sole CFs, a higher performance of 77 ± 8% for 5-fold cross-validation and a hold-out testing performance of 82 + 2% were obtained from ANOVA and ETC. RF+DF obtained a performance of 64 ± 7%, with a hold-out testing performance of 59 ± 2% through ANOVA and XGBC. Usage of CF+RF, CF+DF, and RF+DF+CF enabled the highest averaged accuracies of 78 ± 7%, 78 ± 9%, and 76 ± 8% for 5-fold cross-validation, and hold-out testing accuracies of 81 ± 2%, 82 ± 2%, and 83 ± 4%, respectively. Conclusions: We demonstrated that CFs vitally contribute to predictive performance, and combining them with appropriate imaging features and HMLSs can result in the best prediction performance.Keywords
Funding Information
- Natural Sciences and Engineering Research Council of Canada (NSERC) (RGPIN-2019-06467)
This publication has 75 references indexed in Scilit:
- Diagnostic and screening power of neuropsychological testing in detecting mild cognitive impairment in Parkinson’s diseaseJournal of Neural Transmission, 2013
- Radiomics: the process and the challengesMagnetic Resonance Imaging, 2012
- Rapid eye movement sleep behavior disorder and risk of dementia in Parkinson's disease: A prospective studyMovement Disorders, 2012
- Parkinson's disease: clinical features and diagnosisJournal of Neurology, Neurosurgery & Psychiatry, 2008
- The parkinson's complex: Parkinsonism is just the tip of the icebergAnnals of Neurology, 2006
- The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive ImpairmentJournal of the American Geriatrics Society, 2005
- Greedy function approximation: A gradient boosting machine.The Annals of Statistics, 2001
- The Sydney multicentre study of Parkinson's disease: progression and mortality at 10 yearsJournal of Neurology, Neurosurgery & Psychiatry, 1999
- Artificial neural networks (the multilayer perceptron)—a review of applications in the atmospheric sciencesAtmospheric Environment, 1998
- A Decision-Theoretic Generalization of On-Line Learning and an Application to BoostingJournal of Computer and System Sciences, 1997